Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
Compounds and compositions for modulating EGFR mutant kinase activities
The present invention provides a new group of protein kinase inhibitors, aminopyrimidine derivatives, and pharmaceutically acceptable salts thereof that are useful for treating cell proliferative disease and disorder such as cancer and immune disease. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefore. The invention also provides useful intermediates generated during the syntheses of the aminopyrimidine derivatives.
Yuhan Corporation
A A C A A A A C A A C C A
A61K A61P C07D A61P A61P A61P A61P C07D A61P A61P C07D C07D A61P
additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Jung-Ho Jaekyoo Jaesang Se-Won Byung-Chul In Yong Paresh Devidas Ho-Juhn Dong Sik Jong Sung
Kim Lee Lee Kim Suh Lee Salgaonkar Song Jung Koh